Leibowitch J - Search Results

1

Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro.

Mathez D, Schinazi RF, Liotta DC, Leibowitch J. Mathez D, et al. Among authors: leibowitch j. Antimicrob Agents Chemother. 1993 Oct;37(10):2206-11. doi: 10.1128/AAC.37.10.2206. Antimicrob Agents Chemother. 1993. PMID: 7504908 Free PMC article.

2

Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.

de Truchis P, Assoumou L, Landman R, Mathez D, Le Dû D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C; ANRS 162-4D Study Group. de Truchis P, et al. Among authors: leibowitch j. J Antimicrob Chemother. 2018 Mar 1;73(3):738-747. doi: 10.1093/jac/dkx434. J Antimicrob Chemother. 2018. PMID: 29186458 Clinical Trial.

3

Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.

Mathez D, Bagnarelli P, Gorin I, Katlama C, Pialoux G, Saimot G, Tubiana P, De Truchis P, Chauvin JP, Mills R, Rode R, Clementi M, Leibowitch J. Mathez D, et al. Among authors: leibowitch j. Antivir Ther. 1997 Jul;2(3):175-83. Antivir Ther. 1997. PMID: 11322272

4

Productive human immunodeficiency virus infection levels correlate with AIDS-related manifestations in the patient.

Mathez D, Paul D, de Bélilovsky C, Sultan Y, Deleuze J, Gorin I, Saurin W, Decker R, Leibowitch J. Mathez D, et al. Among authors: leibowitch j. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7438-42. doi: 10.1073/pnas.87.19.7438. Proc Natl Acad Sci U S A. 1990. PMID: 2217174 Free PMC article.

5

HIV expression levels ex vivo: a surrogate marker for clinical endpoints in the evaluation of AIDS treatments?

Mathez D, Paul D, Bélilovsky C, Sultan Y, Gorin I, Deleuze J, Saurin W, Decker R, Leibowitch J. Mathez D, et al. Among authors: leibowitch j. Dev Biol Stand. 1990;72:299-304. Dev Biol Stand. 1990. PMID: 2282988 No abstract available.

6

Short cycles of antiretroviral drugs provide intermittent yet effective therapy: a pilot study in 48 patients with chronic HIV infection.

Leibowitch J, Mathez D, de Truchis P, Perronne C, Melchior JC. Leibowitch J, et al. FASEB J. 2010 Jun;24(6):1649-55. doi: 10.1096/fj.09-148676. Epub 2010 Jan 26. FASEB J. 2010. PMID: 20103716

7

Four days a week or less on appropriate anti-HIV drug combinations provided long-term optimal maintenance in 94 patients: the ICCARRE project.

Leibowitch J, Mathez D, de Truchis P, Ledu D, Melchior JC, Carcelain G, Izopet J, Perronne C, David JR. Leibowitch J, et al. FASEB J. 2015 Jun;29(6):2223-34. doi: 10.1096/fj.14-260315. Epub 2015 Apr 1. FASEB J. 2015. PMID: 25833895

8

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debré P, Leibowitch J. Autran B, et al. Among authors: leibowitch j. Science. 1997 Jul 4;277(5322):112-6. doi: 10.1126/science.277.5322.112. Science. 1997. PMID: 9204894 Clinical Trial.

9

T cell changes after combined nucleoside analogue therapy in HIV primary infection.

Carcelain G, Blanc C, Leibowitch J, Mariot P, Mathez D, Schneider V, Saimot AG, Damond F, Simon F, Debré P, Autran B, Girard PM. Carcelain G, et al. Among authors: leibowitch j. AIDS. 1999 Jun 18;13(9):1077-81. doi: 10.1097/00002030-199906180-00011. AIDS. 1999. PMID: 10397538

10

A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial.

Landman R, de Truchis P, Assoumou L, Lambert S, Bellet J, Amat K, Lefebvre B, Allavena C, Katlama C, Yazdanpanah Y, Molina JM, Petrov-Sanchez V, Gibowski S, Alvarez JC, Leibowitch J, Capeau J, Fellahi S, Duracinsky M, Morand-Joubert L, Costagliola D, Alvarez JC, Girard PM; ANRS 170 QUATUOR study group. Landman R, et al. Among authors: leibowitch j. Lancet HIV. 2022 Feb;9(2):e79-e90. doi: 10.1016/S2352-3018(21)00300-3. Lancet HIV. 2022. PMID: 35120640 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters